Analysis of week 36 data from Phase 2b ORIGIN study shows atacicept 150 mg substantially reduces serum Gd-IgA1 and resolves hematuria in the majority of patients. Additional poster presentations ...
It has been nearly five years since COVID-19 began sweeping across the world. Now, after extensive genetic tracking, scientists say they have discovered the definitive origin of the virus. The ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback